Armin Scheben1, Felix Wolter2, Jacqueline Batley1, Holger Puchta2, David Edwards1. 1. School of Biological Sciences and Institute of Agriculture, University of Western Australia, Perth, WA, 6009, Australia. 2. Botanical Institute II, Karlsruhe Institute of Technology, Karlsruhe, 76131, Germany.
Abstract
Contents 682 I. 682 II. 683 III. 684 IV. 685 V. 685 VI. 688 VII. 690 VIII. 694 694 References 694 SUMMARY: With the rapid increase in the global population and the impact of climate change on agriculture, there is a need for crops with higher yields and greater tolerance to abiotic stress. However, traditional crop improvement via genetic recombination or random mutagenesis is a laborious process and cannot keep pace with increasing crop demand. Genome editing technologies such as clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein (CRISPR/Cas) allow targeted modification of almost any crop genome sequence to generate novel variation and accelerate breeding efforts. We expect a gradual shift in crop improvement away from traditional breeding towards cycles of targeted genome editing. Crop improvement using genome editing is not constrained by limited existing variation or the requirement to select alleles over multiple breeding generations. However, current applications of crop genome editing are limited by the lack of complete reference genomes, the sparse knowledge of potential modification targets, and the unclear legal status of edited crops. We argue that overcoming technical and social barriers to the application of genome editing will allow this technology to produce a new generation of high-yielding, climate ready crops.
Contents 682 I. 682 II. 683 III. 684 IV. 685 V. 685 VI. 688 VII. 690 VIII. 694 694 References 694 SUMMARY: With the rapid increase in the global population and the impact of climate change on agriculture, there is a need for crops with higher yields and greater tolerance to abiotic stress. However, traditional crop improvement via genetic recombination or random mutagenesis is a laborious process and cannot keep pace with increasing crop demand. Genome editing technologies such as clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein (CRISPR/Cas) allow targeted modification of almost any crop genome sequence to generate novel variation and accelerate breeding efforts. We expect a gradual shift in crop improvement away from traditional breeding towards cycles of targeted genome editing. Crop improvement using genome editing is not constrained by limited existing variation or the requirement to select alleles over multiple breeding generations. However, current applications of crop genome editing are limited by the lack of complete reference genomes, the sparse knowledge of potential modification targets, and the unclear legal status of edited crops. We argue that overcoming technical and social barriers to the application of genome editing will allow this technology to produce a new generation of high-yielding, climate ready crops.
Authors: Tobias Jores; Jackson Tonnies; Michael W Dorrity; Josh T Cuperus; Stanley Fields; Christine Queitsch Journal: Plant Cell Date: 2020-05-14 Impact factor: 11.277
Authors: Fabiano Touzdjian Pinheiro Kohlrausch Távora; Francisco de Assis Dos Santos Diniz; Camila de Moraes Rêgo-Machado; Natália Chagas Freitas; Fabrício Barbosa Monteiro Arraes; Eduardo Chumbinho de Andrade; Leila Lourenço Furtado; Karen Ofuji Osiro; Natália Lima de Sousa; Thiago Bérgamo Cardoso; Liliane Márcia Mertz Henning; Patrícia Abrão de Oliveira Molinari; Sérgio Enrique Feingold; Wayne B Hunter; Maria Fátima Grossi de Sá; Adilson Kenji Kobayashi; Alexandre Lima Nepomuceno; Thaís Ribeiro Santiago; Hugo Bruno Correa Molinari Journal: Front Bioeng Biotechnol Date: 2022-06-28
Authors: Karen Massel; Yasmine Lam; Albert C S Wong; Lee T Hickey; Andrew K Borrell; Ian D Godwin Journal: Theor Appl Genet Date: 2021-01-08 Impact factor: 5.699
Authors: Christopher L Barkau; Daniel O'Reilly; Seth B Eddington; Masad J Damha; Keith T Gagnon Journal: Biochem Pharmacol Date: 2021-02-27 Impact factor: 6.100